Literature DB >> 8876846

Trends in cardiovascular disease incidence and survival in the elderly.

M N Haan1, J V Selby, D P Rice, C P Quesenberry, K A Schofield, J Liu, B H Fireman.   

Abstract

This study compared the age-specific incidence, postdiagnostic survival, and mortality for cardiovascular disease (CVD) in two cohorts of people aged 65 years and older. All subjects were members of a large prepaid health maintenance organization. The influence of changes in CVD risk factors on these rates also was evaluated. Trends in prevalence, incidence, postdiagnostic survival, and mortality for CVD were examined in both cohorts in 1971 and 1980. Myocardial infarction (MI), angina pectoris, stroke, and congestive heart failure (CHF) were included as CVD outcomes in this analysis. Nine-year prospective data on these diagnoses were abstracted from medical records and computerized hospitalization records for both cohorts. Age-sex-adjusted cardiovascular mortality was lower for both sexes by approximately 20% in the 1980 cohort. Overall survival did not change, whereas cancer mortality increased by 76% in women and 36% in men. With the exception of stroke, there was no increase in age-adjusted or age-specific prevalence. In men, the age-adjusted prevalence of stroke in men was 24% higher in the 1980 cohort. Age-adjusted 9-year incidence of MI, angina pectoris, stroke, and CHF did not change between cohorts in either sex Postdiagnostic, age-adjusted mortality for men with incident stroke was 24% lower in the 1980 cohort, and Postdiagnostic, age-adjusted mortality for men with incident angina was 35% lower in the 1980 cohort. Adjustment for risk factors measured at or before baseline had little influence on cohort differences in CVD incidence or duration of survival after CVD diagnosis. This study confirms other research showing a decline in CVD mortality over the past 20 years. These findings suggest that prevalent angina pectoris is increasing in men, and that survival with stroke and with angina is improving in men. Later diagnosis of incident CHF in men suggests that prevention and early detection may be postponing the development of more serious disease.

Entities:  

Mesh:

Year:  1996        PMID: 8876846     DOI: 10.1016/s1047-2797(96)00054-3

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  6 in total

1.  Contribution of chronic conditions to aggregate changes in old-age functioning.

Authors:  V A Freedman; L G Martin
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

2.  Lifetime risks of cardiovascular disease.

Authors:  Jarett D Berry; Alan Dyer; Xuan Cai; Daniel B Garside; Hongyan Ning; Avis Thomas; Philip Greenland; Linda Van Horn; Russell P Tracy; Donald M Lloyd-Jones
Journal:  N Engl J Med       Date:  2012-01-26       Impact factor: 91.245

3.  Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: the cardiovascular lifetime risk pooling project.

Authors:  Norrina Allen; Jarett D Berry; Hongyan Ning; Linda Van Horn; Alan Dyer; Donald M Lloyd-Jones
Journal:  Circulation       Date:  2011-12-19       Impact factor: 29.690

4.  Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity.

Authors:  Sadiya S Khan; Hongyan Ning; John T Wilkins; Norrina Allen; Mercedes Carnethon; Jarett D Berry; Ranya N Sweis; Donald M Lloyd-Jones
Journal:  JAMA Cardiol       Date:  2018-04-01       Impact factor: 14.676

5.  Older adults' hemodynamic responses to an acute emotional stressor: short report.

Authors:  Kathi L Heffner; Paul G Devereux; H Mei Ng; Amy R Borchardt; Karen S Quigley
Journal:  Exp Aging Res       Date:  2013       Impact factor: 1.645

6.  Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden.

Authors:  Alessandra Marengoni; Bengt Winblad; Anita Karp; Laura Fratiglioni
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.